The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Clinical Biomarker Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Clinical Biomarker Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Clinical Biomarker Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Drug Discovery accounting for % of the Clinical Biomarker Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cancer segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Clinical Biomarker Testing include Abbott Laboratories, AbbVie Inc., Adaptive Biotechnologies, Agilent Technologies, and BD, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Clinical Biomarker Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Market segment by Application, can be divided into
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Market segment by players, this report covers
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Clinical Biomarker Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Clinical Biomarker Testing, with revenue, gross margin and global market share of Clinical Biomarker Testing from 2019 to 2022.
Chapter 3, the Clinical Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Clinical Biomarker Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Clinical Biomarker Testing research findings and conclusion, appendix and data source.
Geographical Area
Global
The Clinical Biomarker Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Clinical Biomarker Testing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Drug Discovery accounting for % of the Clinical Biomarker Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cancer segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Clinical Biomarker Testing include Abbott Laboratories, AbbVie Inc., Adaptive Biotechnologies, Agilent Technologies, and BD, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Clinical Biomarker Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cancer
Metabolism
Infectious Disease
Cardiology
Neurology
Immunological Disease
Market segment by Application, can be divided into
Drug Discovery
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Market segment by players, this report covers
Abbott Laboratories
AbbVie Inc.
Adaptive Biotechnologies
Agilent Technologies
BD
Becton Dickinson
Bio-Rad Laboratories
Danaher Corporation
Merck and Co.
Thermofisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Clinical Biomarker Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Clinical Biomarker Testing, with revenue, gross margin and global market share of Clinical Biomarker Testing from 2019 to 2022.
Chapter 3, the Clinical Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Clinical Biomarker Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Clinical Biomarker Testing research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Clinical Biomarker Testing
1.2 Classification of Clinical Biomarker Testing by Type
1.2.1 Overview: Global Clinical Biomarker Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Clinical Biomarker Testing Revenue Market Share by Type in 2021
1.2.3 Cancer
1.2.4 Metabolism
1.2.5 Infectious Disease
1.2.6 Cardiology
1.2.7 Neurology
1.2.8 Immunological Disease
1.3 Global Clinical Biomarker Testing Market by Application
1.3.1 Overview: Global Clinical Biomarker Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Drug Discovery
1.3.3 Nutrigenomics
1.3.4 Toxicology Testing
1.3.5 Personalized Medicine
1.3.6 Functional Genomics
1.4 Global Clinical Biomarker Testing Market Size & Forecast
1.5 Global Clinical Biomarker Testing Market Size and Forecast by Region
1.5.1 Global Clinical Biomarker Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Clinical Biomarker Testing Market Size by Region, (2017-2022)
1.5.3 North America Clinical Biomarker Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Clinical Biomarker Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Clinical Biomarker Testing Market Size and Prospect (2017-2028)
1.5.6 South America Clinical Biomarker Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Clinical Biomarker Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Clinical Biomarker Testing Market Drivers
1.6.2 Clinical Biomarker Testing Market Restraints
1.6.3 Clinical Biomarker Testing Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Clinical Biomarker Testing Product and Solutions
2.1.4 Abbott Laboratories Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 AbbVie Inc.
2.2.1 AbbVie Inc. Details
2.2.2 AbbVie Inc. Major Business
2.2.3 AbbVie Inc. Clinical Biomarker Testing Product and Solutions
2.2.4 AbbVie Inc. Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AbbVie Inc. Recent Developments and Future Plans
2.3 Adaptive Biotechnologies
2.3.1 Adaptive Biotechnologies Details
2.3.2 Adaptive Biotechnologies Major Business
2.3.3 Adaptive Biotechnologies Clinical Biomarker Testing Product and Solutions
2.3.4 Adaptive Biotechnologies Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.4 Agilent Technologies
2.4.1 Agilent Technologies Details
2.4.2 Agilent Technologies Major Business
2.4.3 Agilent Technologies Clinical Biomarker Testing Product and Solutions
2.4.4 Agilent Technologies Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Agilent Technologies Recent Developments and Future Plans
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business
2.5.3 BD Clinical Biomarker Testing Product and Solutions
2.5.4 BD Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 BD Recent Developments and Future Plans
2.6 Becton Dickinson
2.6.1 Becton Dickinson Details
2.6.2 Becton Dickinson Major Business
2.6.3 Becton Dickinson Clinical Biomarker Testing Product and Solutions
2.6.4 Becton Dickinson Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Becton Dickinson Recent Developments and Future Plans
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business
2.7.3 Bio-Rad Laboratories Clinical Biomarker Testing Product and Solutions
2.7.4 Bio-Rad Laboratories Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.8 Danaher Corporation
2.8.1 Danaher Corporation Details
2.8.2 Danaher Corporation Major Business
2.8.3 Danaher Corporation Clinical Biomarker Testing Product and Solutions
2.8.4 Danaher Corporation Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Danaher Corporation Recent Developments and Future Plans
2.9 Merck and Co.
2.9.1 Merck and Co. Details
2.9.2 Merck and Co. Major Business
2.9.3 Merck and Co. Clinical Biomarker Testing Product and Solutions
2.9.4 Merck and Co. Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Merck and Co. Recent Developments and Future Plans
2.10 Thermofisher Scientific
2.10.1 Thermofisher Scientific Details
2.10.2 Thermofisher Scientific Major Business
2.10.3 Thermofisher Scientific Clinical Biomarker Testing Product and Solutions
2.10.4 Thermofisher Scientific Clinical Biomarker Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Thermofisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Clinical Biomarker Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Clinical Biomarker Testing Players Market Share in 2021
3.2.2 Top 10 Clinical Biomarker Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Clinical Biomarker Testing Players Head Office, Products and Services Provided
3.4 Clinical Biomarker Testing Mergers & Acquisitions
3.5 Clinical Biomarker Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Clinical Biomarker Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Clinical Biomarker Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Clinical Biomarker Testing Revenue Market Share by Application (2017-2022)
5.2 Global Clinical Biomarker Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Clinical Biomarker Testing Revenue by Type (2017-2028)
6.2 North America Clinical Biomarker Testing Revenue by Application (2017-2028)
6.3 North America Clinical Biomarker Testing Market Size by Country
6.3.1 North America Clinical Biomarker Testing Revenue by Country (2017-2028)
6.3.2 United States Clinical Biomarker Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Clinical Biomarker Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Clinical Biomarker Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Clinical Biomarker Testing Revenue by Type (2017-2028)
7.2 Europe Clinical Biomarker Testing Revenue by Application (2017-2028)
7.3 Europe Clinical Biomarker Testing Market Size by Country
7.3.1 Europe Clinical Biomarker Testing Revenue by Country (2017-2028)
7.3.2 Germany Clinical Biomarker Testing Market Size and Forecast (2017-2028)
7.3.3 France Clinical Biomarker Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Clinical Biomarker Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Clinical Biomarker Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Clinical Biomarker Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Clinical Biomarker Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Clinical Biomarker Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Clinical Biomarker Testing Market Size by Region
8.3.1 Asia-Pacific Clinical Biomarker Testing Revenue by Region (2017-2028)
8.3.2 China Clinical Biomarker Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Clinical Biomarker Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Clinical Biomarker Testing Market Size and Forecast (2017-2028)
8.3.5 India Clinical Biomarker Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Clinical Biomarker Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Clinical Biomarker Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Clinical Biomarker Testing Revenue by Type (2017-2028)
9.2 South America Clinical Biomarker Testing Revenue by Application (2017-2028)
9.3 South America Clinical Biomarker Testing Market Size by Country
9.3.1 South America Clinical Biomarker Testing Revenue by Country (2017-2028)
9.3.2 Brazil Clinical Biomarker Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Clinical Biomarker Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Clinical Biomarker Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Clinical Biomarker Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Clinical Biomarker Testing Market Size by Country
10.3.1 Middle East & Africa Clinical Biomarker Testing Revenue by Country (2017-2028)
10.3.2 Turkey Clinical Biomarker Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Clinical Biomarker Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Clinical Biomarker Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Clinical Biomarker Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Clinical Biomarker Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Clinical Biomarker Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Clinical Biomarker Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Clinical Biomarker Testing Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Clinical Biomarker Testing Product and Solutions
Table 9. Abbott Laboratories Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AbbVie Inc. Corporate Information, Head Office, and Major Competitors
Table 11. AbbVie Inc. Major Business
Table 12. AbbVie Inc. Clinical Biomarker Testing Product and Solutions
Table 13. AbbVie Inc. Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Adaptive Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 15. Adaptive Biotechnologies Major Business
Table 16. Adaptive Biotechnologies Clinical Biomarker Testing Product and Solutions
Table 17. Adaptive Biotechnologies Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies Major Business
Table 20. Agilent Technologies Clinical Biomarker Testing Product and Solutions
Table 21. Agilent Technologies Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. BD Corporate Information, Head Office, and Major Competitors
Table 23. BD Major Business
Table 24. BD Clinical Biomarker Testing Product and Solutions
Table 25. BD Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 27. Becton Dickinson Major Business
Table 28. Becton Dickinson Clinical Biomarker Testing Product and Solutions
Table 29. Becton Dickinson Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Major Business
Table 32. Bio-Rad Laboratories Clinical Biomarker Testing Product and Solutions
Table 33. Bio-Rad Laboratories Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Danaher Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Danaher Corporation Major Business
Table 36. Danaher Corporation Clinical Biomarker Testing Product and Solutions
Table 37. Danaher Corporation Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Merck and Co. Corporate Information, Head Office, and Major Competitors
Table 39. Merck and Co. Major Business
Table 40. Merck and Co. Clinical Biomarker Testing Product and Solutions
Table 41. Merck and Co. Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Thermofisher Scientific Corporate Information, Head Office, and Major Competitors
Table 43. Thermofisher Scientific Major Business
Table 44. Thermofisher Scientific Clinical Biomarker Testing Product and Solutions
Table 45. Thermofisher Scientific Clinical Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Clinical Biomarker Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Clinical Biomarker Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Clinical Biomarker Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Clinical Biomarker Testing Players Head Office, Products and Services Provided
Table 50. Clinical Biomarker Testing Mergers & Acquisitions in the Past Five Years
Table 51. Clinical Biomarker Testing New Entrants and Expansion Plans
Table 52. Global Clinical Biomarker Testing Revenue (USD Million) by Type (2017-2022)
Table 53. Global Clinical Biomarker Testing Revenue Share by Type (2017-2022)
Table 54. Global Clinical Biomarker Testing Revenue Forecast by Type (2023-2028)
Table 55. Global Clinical Biomarker Testing Revenue by Application (2017-2022)
Table 56. Global Clinical Biomarker Testing Revenue Forecast by Application (2023-2028)
Table 57. North America Clinical Biomarker Testing Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Clinical Biomarker Testing Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Clinical Biomarker Testing Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Clinical Biomarker Testing Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Clinical Biomarker Testing Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Clinical Biomarker Testing Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Clinical Biomarker Testing Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Clinical Biomarker Testing Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Clinical Biomarker Testing Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Clinical Biomarker Testing Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Clinical Biomarker Testing Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Clinical Biomarker Testing Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Clinical Biomarker Testing Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Clinical Biomarker Testing Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Clinical Biomarker Testing Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Clinical Biomarker Testing Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Clinical Biomarker Testing Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Clinical Biomarker Testing Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Clinical Biomarker Testing Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Clinical Biomarker Testing Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Clinical Biomarker Testing Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Clinical Biomarker Testing Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Clinical Biomarker Testing Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Clinical Biomarker Testing Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Clinical Biomarker Testing Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Clinical Biomarker Testing Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Clinical Biomarker Testing Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Clinical Biomarker Testing Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Clinical Biomarker Testing Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Clinical Biomarker Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Clinical Biomarker Testing Picture
Figure 2. Global Clinical Biomarker Testing Revenue Market Share by Type in 2021
Figure 3. Cancer
Figure 4. Metabolism
Figure 5. Infectious Disease
Figure 6. Cardiology
Figure 7. Neurology
Figure 8. Immunological Disease
Figure 9. Clinical Biomarker Testing Revenue Market Share by Application in 2021
Figure 10. Drug Discovery Picture
Figure 11. Nutrigenomics Picture
Figure 12. Toxicology Testing Picture
Figure 13. Personalized Medicine Picture
Figure 14. Functional Genomics Picture
Figure 15. Global Clinical Biomarker Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 16. Global Clinical Biomarker Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Clinical Biomarker Testing Revenue Market Share by Region (2017-2028)
Figure 18. Global Clinical Biomarker Testing Revenue Market Share by Region in 2021
Figure 19. North America Clinical Biomarker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Europe Clinical Biomarker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Asia-Pacific Clinical Biomarker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. South America Clinical Biomarker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Middle East and Africa Clinical Biomarker Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Clinical Biomarker Testing Market Drivers
Figure 25. Clinical Biomarker Testing Market Restraints
Figure 26. Clinical Biomarker Testing Market Trends
Figure 27. Abbott Laboratories Recent Developments and Future Plans
Figure 28. AbbVie Inc. Recent Developments and Future Plans
Figure 29. Adaptive Biotechnologies Recent Developments and Future Plans
Figure 30. Agilent Technologies Recent Developments and Future Plans
Figure 31. BD Recent Developments and Future Plans
Figure 32. Becton Dickinson Recent Developments and Future Plans
Figure 33. Bio-Rad Laboratories Recent Developments and Future Plans
Figure 34. Danaher Corporation Recent Developments and Future Plans
Figure 35. Merck and Co. Recent Developments and Future Plans
Figure 36. Thermofisher Scientific Recent Developments and Future Plans
Figure 37. Global Clinical Biomarker Testing Revenue Share by Players in 2021
Figure 38. Clinical Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 39. Global Top 3 Players Clinical Biomarker Testing Revenue Market Share in 2021
Figure 40. Global Top 10 Players Clinical Biomarker Testing Revenue Market Share in 2021
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 42. Global Clinical Biomarker Testing Revenue Share by Type in 2021
Figure 43. Global Clinical Biomarker Testing Market Share Forecast by Type (2023-2028)
Figure 44. Global Clinical Biomarker Testing Revenue Share by Application in 2021
Figure 45. Global Clinical Biomarker Testing Market Share Forecast by Application (2023-2028)
Figure 46. North America Clinical Biomarker Testing Sales Market Share by Type (2017-2028)
Figure 47. North America Clinical Biomarker Testing Sales Market Share by Application (2017-2028)
Figure 48. North America Clinical Biomarker Testing Revenue Market Share by Country (2017-2028)
Figure 49. United States Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Canada Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Mexico Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Europe Clinical Biomarker Testing Sales Market Share by Type (2017-2028)
Figure 53. Europe Clinical Biomarker Testing Sales Market Share by Application (2017-2028)
Figure 54. Europe Clinical Biomarker Testing Revenue Market Share by Country (2017-2028)
Figure 55. Germany Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. France Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. United Kingdom Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Russia Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Italy Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Asia-Pacific Clinical Biomarker Testing Sales Market Share by Type (2017-2028)
Figure 61. Asia-Pacific Clinical Biomarker Testing Sales Market Share by Application (2017-2028)
Figure 62. Asia-Pacific Clinical Biomarker Testing Revenue Market Share by Region (2017-2028)
Figure 63. China Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Japan Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South Korea Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. India Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Southeast Asia Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Australia Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. South America Clinical Biomarker Testing Sales Market Share by Type (2017-2028)
Figure 70. South America Clinical Biomarker Testing Sales Market Share by Application (2017-2028)
Figure 71. South America Clinical Biomarker Testing Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East and Africa Clinical Biomarker Testing Sales Market Share by Type (2017-2028)
Figure 75. Middle East and Africa Clinical Biomarker Testing Sales Market Share by Application (2017-2028)
Figure 76. Middle East and Africa Clinical Biomarker Testing Revenue Market Share by Country (2017-2028)
Figure 77. Turkey Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. UAE Clinical Biomarker Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
